Maintenance Bevacizumab or Observation After Taxane Based First Line Chemotherapy Plus Bevacizumab in Women With HER2-Negative Metastatic Breast Cancer. An Observational Study.
Phase of Trial: Phase IV
Latest Information Update: 09 Oct 2015
At a glance
- Drugs Bevacizumab (Primary)
- Indications Breast cancer
- Focus Adverse reactions
- 25 Sep 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 21 Nov 2013 New trial record